Sonnet BioTherapeutics Holdings's total assets for Q1 2025 were $7.18M, an increase of 159.18% from the previous quarter. SONN total liabilities were $3.15M for the fiscal quarter, a -3.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.